As of 2025-07-07, the Relative Valuation of 10X Genomics Inc (TXG) is (36.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.01 USD, the upside of 10X Genomics Inc based on Relative Valuation is -381.3%.
The range of the Relative Valuation is (37.78) - (36.55) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.6x - 31.3x | 29.7x |
| Forward P/E multiples | 26.2x - 28.7x | 27.7x |
| Fair Price | (37.78) - (36.55) | (36.60) |
| Upside | -390.4% - -381.0% | -381.3% |
| Date | P/E |
| 2025-07-03 | -10.20 |
| 2025-07-02 | -10.20 |
| 2025-07-01 | -9.46 |
| 2025-06-30 | -9.08 |
| 2025-06-27 | -9.20 |
| 2025-06-26 | -9.17 |
| 2025-06-25 | -9.14 |
| 2025-06-24 | -8.54 |
| 2025-06-23 | -8.46 |
| 2025-06-20 | -8.48 |
| 2025-06-18 | -8.52 |
| 2025-06-17 | -8.28 |
| 2025-06-16 | -8.63 |
| 2025-06-13 | -8.17 |
| 2025-06-12 | -8.30 |
| 2025-06-11 | -8.45 |
| 2025-06-10 | -8.35 |
| 2025-06-09 | -7.91 |
| 2025-06-06 | -7.39 |
| 2025-06-05 | -7.14 |
| 2025-06-04 | -7.32 |
| 2025-06-03 | -7.14 |
| 2025-06-02 | -7.41 |
| 2025-05-30 | -7.47 |
| 2025-05-29 | -7.32 |
| 2025-05-28 | -6.95 |
| 2025-05-27 | -6.74 |
| 2025-05-23 | -6.41 |
| 2025-05-22 | -6.70 |
| 2025-05-21 | -6.52 |
| 2025-05-20 | -7.12 |
| 2025-05-19 | -7.00 |
| 2025-05-16 | -7.36 |
| 2025-05-15 | -7.21 |
| 2025-05-14 | -7.15 |
| 2025-05-13 | -7.57 |
| 2025-05-12 | -7.44 |
| 2025-05-09 | -6.88 |
| 2025-05-08 | -6.77 |
| 2025-05-07 | -6.52 |
| 2025-05-06 | -6.35 |
| 2025-05-05 | -6.75 |
| 2025-05-02 | -6.61 |
| 2025-05-01 | -6.35 |
| 2025-04-30 | -6.48 |
| 2025-04-29 | -6.57 |
| 2025-04-28 | -6.65 |
| 2025-04-25 | -6.51 |
| 2025-04-24 | -6.52 |
| 2025-04-23 | -6.28 |